Twist Bioscience (NASDAQ: TWST)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-05 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -1.280 | -1.130 | 0.1500 | ||||
REV | 45.250M | 48.127M | 2.877M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Twist Bioscience (NASDAQ: TWST) through any online brokerage.
Other companies in Twist Bioscience’s space includes: Sage Therapeutics (NASDAQ:SAGE), Fate Therapeutics (NASDAQ:FATE), Xencor (NASDAQ:XNCR), ChemoCentryx (NASDAQ:CCXI) and PTC Therapeutics (NASDAQ:PTCT).
The latest price target for Twist Bioscience (NASDAQ: TWST) was reported by Barclays on Monday, May 9, 2022. The analyst firm set a price target for 40.00 expecting TWST to rise to within 12 months (a possible 15.04% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Twist Bioscience (NASDAQ: TWST) is $34.77 last updated June 29, 2022, 8:00 PM UTC.
There are no upcoming dividends for Twist Bioscience.
Twist Bioscience’s Q3 earnings are confirmed for Friday, August 5, 2022.
There is no upcoming split for Twist Bioscience.
Twist Bioscience is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.